Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00145977 · ClinicalTrials.gov registry record · NA
Texture Analysis for Postmenopausal Osteoporosis
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT00145977: Completed NA study, sponsored by University of Chicago.
NCT00145977 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00145977, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a new test for osteoporosis can be useful in monitoring treatment. We are studying a new method for examining the quality of bone by an experimental method of computerized analysis of radiographic images (x-ray pictures) of the heel.
Primary Outcome
Percent Change in lumbar spine BMD from Baseline to Month 24
Interventions
- DIETARY_SUPPLEMENT Vitamin D
- DRUG Alendronate
- DIETARY_SUPPLEMENT Calcium Citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2001-07 |
| Est. Completion | 2009-12 |
| Phase | NA |
What the finished NCT00145977 record still lists
NCT00145977 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Vitamin D is the first listed.
NCT00145977 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00145977 about?
NCT00145977 is a clinical study titled "Texture Analysis for Postmenopausal Osteoporosis". The purpose of this study is to determine if a new test for osteoporosis can be useful in monitoring treatment. We are studying a new method for examining the quality of bone by an experimental method of computerized analysis of radiographic images (x-ray pictures) of the heel.
What is the current status of trial NCT00145977?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2001-07. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00145977?
The interventions under investigation include: Vitamin D (DIETARY_SUPPLEMENT), Alendronate (DRUG), Calcium Citrate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00145977?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00145977's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia